Rabeprazole Domperidone Pellets Manufacturer & Supplier

Anti-Ulcerant (PPIs) • Pellets

Combination pellets offering relief from acid reflux and associated nausea, maintaining uniformity across fills.

20 mg + 30 mg
  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Rabeprazole provides proton pump inhibition, while Domperidone is used as the prokinetic component. Rraynex focuses on uniform pellet density, particle-size control, formulation compatibility, and downstream capsule or sachet processing. Technical packages can include dissolution, impurity, stability, and formulation-development information according to project requirements.

Key characteristics

  • Dual-API combination pellets.
  • Controlled enteric protection for the PPI component.
  • Balanced pellet characteristics for homogeneous filling.
  • Suitable for capsule and sachet formulations.
  • Support for pharmaceutical development and commercial scale-up.

Product specifications

Product
Rabeprazole Domperidone Pellets
Form
Pellets
Therapeutic category
Anti-Ulcerant (PPIs)
Strength
20 mg + 30 mg
Grade
IP / BP / USP / EP
Pack size
25/50 kg
Site certifications
WHO-GMP, ISO 9001, ISO 14001

Detailed specifications, COA and technical documentation are shared on request.

Supply and enquiries

Rraynex supplies Rabeprazole Domperidone Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.

Send product enquiry Browse all pellets Manufacturing capabilities

Other Rabeprazole products from Rraynex

Frequently asked questions

Enquire Now